Cargando…

Corrigendum to ‘MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway’ [EBioMedicine 46 (2019) 66–78]

Detalles Bibliográficos
Autores principales:	Wang, Wei-Wei, Zhao, Zhi-Hua, Wang, Li, Li, Pan, Chen, Kui-Sheng, Zhang, Jian-Ying, Li, Wen-Cai, Jiang, Guo-Zhong, Li, Xiang-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251239/ https://www.ncbi.nlm.nih.gov/pubmed/32416443 http://dx.doi.org/10.1016/j.ebiom.2020.102772

Ejemplares similares

Corrigendum to ‘Combined gene essentiality scoring improves the prediction of cancer dependency maps’ [EBioMedicine 50 (2019) 66–79]
por: Wang, Wenyu, et al.
Publicado: (2020)

Corrigendum to “Syk and ye shall find” [EBioMedicine 2 (11) (2015) 190-1591]
por: Wolozin, Benjamin, et al.
Publicado: (2016)

Corrigendum to “Cholangiopathies – Towards a molecular understanding” [EBioMedicine 35 (2018) 381–393]
por: Tam, Paul K.H., et al.
Publicado: (2018)

Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604]
por: Qi, Zhaolai, et al.
Publicado: (2020)

Corrigendum to ‘Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis’ [EBioMedicine 41 (2019) 538–555]
por: He, Xiaojuan, et al.
Publicado: (2020)

Corrigendum to “Allergic Conjunctivitis-induced Retinal Inflammation Promotes Myopia Progression” [EBioMedicine 28 (2018) 274–286]
por: Wei, Chang-Ching, et al.
Publicado: (2019)

Corrigendum to “Intergenerational Transmission of Enhanced Seizure Susceptibility after Febrile Seizures” (EBioMedicine 17 (2017) 206–215)
por: Wu, Dengchang, et al.
Publicado: (2017)

Corrigendum to ‘Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apc(min)(/+) mice’ [EBioMedicine 48 (2019) 301–315]
por: Li, Lu, et al.
Publicado: (2020)

Corrigendum to “TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice” [EBioMedicine (2018) 54–62]
por: Wang, Zhen, et al.
Publicado: (2018)

Corrigendum to “Linezolid for Treating Tuberculosis: A Delicate Balancing Act” [EBioMedicine 2 (11) (November 2015) 1568–1569]
Publicado: (2015)

Corrigendum to “Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases” [EBioMedicine 54 (2020) 102730]
por: Tan, Jing, et al.
Publicado: (2020)

Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
por: Sun, Zhiwei, et al.
Publicado: (2021)

Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]
por: Tan, Wenliang, et al.
Publicado: (2022)

Corrigendum to ‘single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis’ [EBioMedicine 53 (2020) 102686]
por: Cai, Yi, et al.
Publicado: (2022)

Corrigendum to ‘Silencing KIF18B enhances radiosensitivity: Identification of a promising therapeutic target in sarcoma’ [EBioMedicine 61 (2020) 103,056]
por: Liu, Wensi, et al.
Publicado: (2021)

Corrigendum to ‘Silencing of circular RNA HIPK2 in neural stem cells enhances functional recovery following ischaemic stroke’ [EBioMedicine 52 (2020) 102660]
por: Wang, Guangtian, et al.
Publicado: (2020)

Corrigendum to “Serotonin Activates Bacterial Quorum Sensing and Enhances the Virulence of Pseudomonas aeruginosa in the Host” [EBioMedicine 9 (2016) 161–169]
por: Knecht, Leslie D., et al.
Publicado: (2017)

Corrigendum to “Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging” EBioMedicine 35 (2018) 270–278
por: Wu, Qian, et al.
Publicado: (2018)

MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway
por: Wang, Wei-Wei, et al.
Publicado: (2019)

Corrigendum to ‘Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor’: [EBioMedicine 54 (2020) 102719]
por: Gadaleta, Raffaella Maria, et al.
Publicado: (2020)

Corrigendum to “Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease” [EBioMedicine 37 (2018) 269–280]
por: Shu, Shaoqun, et al.
Publicado: (2021)

Corrigendum to “poFUT1 promotes endometrial decidualization by enhancing the O-fucosylation of Notch1” [EBioMedicine 44 (2019) 563–573]
por: Yang, Yu, et al.
Publicado: (2023)

Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2019)

Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
por: Wu, Mengjiao, et al.
Publicado: (2021)

Corrigendum to: “Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers” [EBioMedicine 8 (2016) 117–131]
por: Illendula, Anuradha, et al.
Publicado: (2017)

Corrigendum to “APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP” [EBioMedicine (2019)]
por: Gong, Huiyuan, et al.
Publicado: (2019)

Corrigendum to “Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer” (EBioMedicine Aug 2016; 10: 124–36)
por: Wei, Tzu-Tang
Publicado: (2017)

Corrigendum to “Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation”: [EBioMedicine 48 (2019) 316–331]
por: Yan, Dong, et al.
Publicado: (2021)

Corrigendum to “Carbon monoxide releasing molecule-3 alleviates neuron death after spinal cord injury via inflammasome regulation” [EBioMedicine 40 (2019) 643–654]
por: Zheng, Gang, et al.
Publicado: (2021)

Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275>
por: Gan, Yu, et al.
Publicado: (2020)

Corrigendum to “the long noncoding RNA MEG3 and its target miR-147 regulate JAK/STAT pathway in advanced chronic myeloid leukemia” [EBioMedicine 35 (2018) 61–75]
por: Li, Zi-ye, et al.
Publicado: (2018)

Corrigendum to “Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge” [EBioMedicine 2 (2015) 1438-1446]
por: Lan, Jiaming, et al.
Publicado: (2021)

Corrigendum to “Increased BOLD Signals Elicited by High Gamma Auditory Stimulation of the Left Auditory Cortex in Acute State Schizophrenia” [EBioMedicine 12 (2016) 143-149]
por: Kuga, Hironori, et al.
Publicado: (2017)

Corrigendum to “Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's disease” [EBioMedicine 2 (2015) 294–305]
por: Zhang, Liang, et al.
Publicado: (2019)

Corrigendum to ‘Cyclic AMP-Responsive element-binding protein (CREB) is critical in autoimmunity by promoting Th17 but inhibiting treg cell differentiation’: [EBioMedicine 25 (2017) 165–174]
por: Wang, Xiaohu, et al.
Publicado: (2020)

Corrigendum to “comparative exome sequencing reveals novel candidate genes for retinitis pigmentosa” [EBioMedicine 56(2020)102792] DOI: https://doi.org/10.1016/j.ebiom.2020.102792
por: Yi, Zhen, et al.
Publicado: (2022)

Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144]
por: Ross-Adams, H., et al.
Publicado: (2017)

Corrigendum to ‘‘Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model’’ [EBioMedicine 41 (2019) 465–478]
por: Nivarthi, Usha K., et al.
Publicado: (2020)

Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95]
por: Vega, Francisco M., et al.
Publicado: (2020)

Corrigendum to ‘‘Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type’’ [EBioMedicine 51 (2020) 102526]
por: Cai, Qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fklbi64a4fprk51pfre4l7d17g